Scientific breakthroughs are transforming cancer care. Targeted therapies and immunotherapies produce durable remissions, but only for some patients and resistance remains. Will either of these singular approaches cure cancer? Or will a combination rock the world? The initial data is intriguing. But is it compelling?
Join BIDMC’s 11th annual cancer symposium to witness the debate and hear progress reports from today’s foremost cancer researchers.
Hosted by Pier Paolo Pandolfi, MD, PhD
Director, Cancer Center and Cancer Research Institute at Beth Israel Deaconess Medical Center
Register today: bidmc.org/cancersymposium
Info: 617-735-2642 or email@example.com